<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chagnon-Choquet J</submitter><funding>Alberta Innovates</funding><funding>Canadian Institutes of Health Research</funding><pagination>e101949</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4087016</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(7)</volume><pubmed_abstract>Understanding how the immune system facilitates or controls HIV-1 disease progression has important implications for the design of effective interventions. We report that although B-cell dysregulations associated with HIV-1 disease progression are accompanied by an overall decrease in the percentage of total blood B-cells, we observe an increase in relative frequencies of cells presenting characteristics of both transitional immature and first-line marginal zone (MZ) B-cell populations, we designated as precursor MZ-like B-cells. B-cells with similar attributes have been associated with IL-10 expression and "regulatory" potential. As such, the relative frequencies of precursor MZ-like B-cells expressing IL-10 are increased in the blood of viremic HIV-1-infected individuals when compared to</pubmed_abstract><journal>PloS one</journal><pubmed_title>IL-10 and lymphotoxin-α expression profiles within marginal zone-like B-cell populations are associated with control of HIV-1 disease progression.</pubmed_title><pmcid>PMC4087016</pmcid><funding_grant_id>126633</funding_grant_id><funding_grant_id>201201140</funding_grant_id><pubmed_authors>Vezina S</pubmed_authors><pubmed_authors>Huchet E</pubmed_authors><pubmed_authors>Bernard N</pubmed_authors><pubmed_authors>Lessard B</pubmed_authors><pubmed_authors>Rouleau D</pubmed_authors><pubmed_authors>Roger M</pubmed_authors><pubmed_authors>Cote P</pubmed_authors><pubmed_authors>Poudrier J</pubmed_authors><pubmed_authors>Baril JG</pubmed_authors><pubmed_authors>Charron MA</pubmed_authors><pubmed_authors>Bruneau J</pubmed_authors><pubmed_authors>Potter M</pubmed_authors><pubmed_authors>Charest L</pubmed_authors><pubmed_authors>lalonde R</pubmed_authors><pubmed_authors>Thomas R</pubmed_authors><pubmed_authors>Vassal A</pubmed_authors><pubmed_authors>Munoz M</pubmed_authors><pubmed_authors>Milne C</pubmed_authors><pubmed_authors>Tremblay C</pubmed_authors><pubmed_authors>Slow Progressor Study Group</pubmed_authors><pubmed_authors>Legault M</pubmed_authors><pubmed_authors>Gilmore N</pubmed_authors><pubmed_authors>Szabo J</pubmed_authors><pubmed_authors>Klein M</pubmed_authors><pubmed_authors>Montreal Primary HIV Infection Study Group</pubmed_authors><pubmed_authors>Fontaine J</pubmed_authors><pubmed_authors>de Pokomandy A</pubmed_authors><pubmed_authors>Labrecque L</pubmed_authors><pubmed_authors>Fortin C</pubmed_authors><pubmed_authors>Trottier B</pubmed_authors><pubmed_authors>Friedman J</pubmed_authors><pubmed_authors>Routy JP</pubmed_authors><pubmed_authors>Dufresne S</pubmed_authors><pubmed_authors>LeBlanc R</pubmed_authors><pubmed_authors>Chagnon-Choquet J</pubmed_authors></additional><is_claimable>false</is_claimable><name>IL-10 and lymphotoxin-α expression profiles within marginal zone-like B-cell populations are associated with control of HIV-1 disease progression.</name><description>Understanding how the immune system facilitates or controls HIV-1 disease progression has important implications for the design of effective interventions. We report that although B-cell dysregulations associated with HIV-1 disease progression are accompanied by an overall decrease in the percentage of total blood B-cells, we observe an increase in relative frequencies of cells presenting characteristics of both transitional immature and first-line marginal zone (MZ) B-cell populations, we designated as precursor MZ-like B-cells. B-cells with similar attributes have been associated with IL-10 expression and "regulatory" potential. As such, the relative frequencies of precursor MZ-like B-cells expressing IL-10 are increased in the blood of viremic HIV-1-infected individuals when compared to</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014</publication><modification>2025-04-18T21:44:00.576Z</modification><creation>2019-03-26T23:26:26Z</creation></dates><accession>S-EPMC4087016</accession><cross_references><pubmed>25003989</pubmed><doi>10.1371/journal.pone.0101949</doi></cross_references></HashMap>